Outsized Ventures

Magdrive Limited, founded in 2019 and based in Didcot, United Kingdom, focuses on developing advanced spacecraft propulsion systems specifically for small satellites. The company has created a next-generation plasma thruster technology that merges the high thrust capabilities of chemical rockets with the efficiency of electric thrusters. This innovation allows spacecraft to achieve faster speeds and extend mission durations while minimizing the amount of propellant needed for various maneuvers. By improving fuel efficiency, Magdrive aims to provide satellite operators and manufacturers with a more cost-effective means of accessing space, particularly for missions in Low Earth Orbit.

Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.

MixRift is a gaming company focused on creating interactive and mixed-reality gaming experiences. It operates a gaming studio that develops a variety of entertainment games, including survival and puzzle genres. The company's offerings aim to provide immersive experiences that seamlessly blend virtual and real-world elements, enhancing the overall engagement for gamers.

Julienne Bruno is a producer of plant-based food products that aims to transform alternative food options. The company specializes in creating cheese and salami-based items made from naturally derived ingredients, such as fermented legumes and slow-roasted vegetables, without the use of dairy or meat. By focusing on nutritional ingredients, Julienne Bruno provides customers with innovative food dishes that cater to a growing demand for plant-based alternatives.

Emitwise Ltd is a London-based company that develops software solutions for carbon footprint management. Founded in 2019, Emitwise offers a unique platform that leverages artificial intelligence to enable businesses to automatically measure, report, and reduce their carbon emissions across operations and supply chains. The company's technology facilitates real-time tracking of carbon footprints, allowing organizations to implement cost-effective strategies that align with sustainability targets. Emitwise aims to empower companies to respond to the climate emergency and transition towards a net-zero carbon future by providing the necessary tools to drive emissions reductions effectively. The company has gained the trust of global businesses and is supported by prominent investors from Silicon Valley.

Molecule One is a biotechnology company that specializes in artificial intelligence-driven software for chemical synthesis. Its m1 platform enhances the preclinical pipeline by providing tools that assist bench chemists, data scientists, and computational chemists in their work. The software is designed to predict the likelihood of synthesizing novel small molecules, streamlining the synthesis design process by automating significant portions of manual tasks. By leveraging vast amounts of data that exceed human processing capabilities, Molecule One enables clients to concentrate on drug candidates with lower synthesis costs and a higher probability of success.

Treos Bio is a clinical-stage biotechnology company focused on developing precision cancer immunotherapies tailored to the genetic profiles of patients. Founded in 2013 and based in San Francisco, California, the company utilizes proprietary technology and computational data science to predict individual responses to cancer treatments. Its product offerings include PEPI, a test that analyzes genetic data from saliva or blood samples to forecast immune responses, and PolyPEPI immunotherapy vaccines targeting various cancers such as melanoma, lung cancer, and breast cancer. Additionally, Treos Bio provides the PolyPEPI CDx companion diagnostic test, which helps determine the effectiveness of treatments for specific patients, allowing for personalized vaccine design. The company also offers a melanoma screening test to identify individuals at high risk for developing the disease based on genetic information.

Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a combination of cell biology and mathematical modeling to cultivate purified animal fat in bioreactors. This innovative approach provides a sustainable and cruelty-free ingredient for the meat alternatives industry, as well as applications in other sectors such as bakery, confectionery, and cosmetics. By focusing on cultivated fat, Hoxton Farms aims to meet the growing demand for ethical and environmentally friendly food products.

Living Optics Limited, founded in 2019 and based in Oxford, United Kingdom, specializes in the design and development of compact hyperspectral imaging cameras and related software. The company's innovative technology captures data that is not visible to the human eye or traditional cameras, making hyperspectral imaging more accessible and affordable for a variety of applications in consumer products, medical devices, and the manufacturing industry. Living Optics aims to empower computer vision developers and scientists by providing portable solutions that enable the integration of spectral imaging data into new research and applications. In September 2022, the company secured $25 million in Series A funding to further its mission of revolutionizing the imaging market.

Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a combination of cell biology and mathematical modeling to cultivate purified animal fat in bioreactors. This innovative approach provides a sustainable and cruelty-free ingredient for the meat alternatives industry, as well as applications in other sectors such as bakery, confectionery, and cosmetics. By focusing on cultivated fat, Hoxton Farms aims to meet the growing demand for ethical and environmentally friendly food products.

Kernal Biologics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on designing and developing mRNA immunotherapies for diseases such as COVID-19 and cancer. Founded in 2016, the company utilizes its mRNA platform to enable specific cells to produce their own therapeutic agents. Kernal's innovative approach has garnered recognition, including awards from notable organizations like Amgen and NASA. The team behind Kernal Biologics has strong ties to prestigious institutions such as MIT and Harvard, along with extensive experience in the biotech sector, which underpins their expertise in the mRNA field.

Fathom Radiant was created on the premise of applying first-principles thinking to create technology capable of enabling artificial general intelligence for the benefit of all. The company does not believe that the beneficial advancement of AI is unavoidable, and Faathom believes that as a company offering a critical layer in the AI technology stack, we can make a difference in how securely advanced AI systems are built and deployed.

Mahana Therapeutics, Inc. is a healthcare company focused on developing digital treatments for individuals with gastrointestinal diseases, particularly irritable bowel syndrome (IBS). The company offers a clinically validated application called Parallel, which provides a minimal-contact digital program aimed at improving the quality of life for patients suffering from IBS. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also has an office in London, United Kingdom. The company's solutions are designed to deliver both physical and psychological support, ensuring that patients receive clinically proven assistance to help them manage their chronic health conditions effectively.